We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current INVA market cap is 1.18B. The company's latest EPS is USD 2.8709 and P/E is 6.60.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 80.99M | 67.26M | 85.84M | 77.5M | 99.9M |
| Operating Income | 28.52M | 85.83M | 37.53M | 25.81M | 54.69M |
| Net Income | 1.28M | 82.05M | 61.53M | 36.53M | -34.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 261.02M | 336.79M | 391.87M | 331.34M | 310.46M |
| Operating Income | 246.36M | 321.12M | 375.1M | 207M | 113.89M |
| Net Income | 157.29M | 224.4M | 265.85M | 213.92M | 179.72M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.12B | 1.19B | 1.24B | 1.27B | 1.22B |
| Total Liabilities | 563.15M | 560.61M | 568.55M | 563.93M | 559.4M |
| Total Equity | 555.09M | 627.49M | 674.96M | 703.68M | 665.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 724.83M | 999.57M | 926.4M | 1.23B | 1.24B |
| Total Liabilities | 382.71M | 391.73M | 400.46M | 665.71M | 568.55M |
| Total Equity | 342.12M | 607.84M | 525.94M | 565.79M | 674.96M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 63.87M | 107.81M | 141.06M | 37.05M | 80.77M |
| Investing | -35.72M | -61.61M | -66.76M | -43.04M | -43.04M |
| Financing | -146.17M | -157.25M | -171.84M | -9.17M | -14.24M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 257.46M | 313.11M | 363.81M | 201.73M | 141.06M |
| Investing | -18M | -314.94M | 43.72M | -56.63M | -66.76M |
| Financing | -23.78M | -29.79M | -452.5M | -55.57M | -171.84M |
| Market Cap | 1.18B |
| Price to Earnings Ratio | 6.60 |
| Price to Sales Ratio | 3.82 |
| Price to Cash Ratio | 6.13 |
| Price to Book Ratio | 1.76 |
| Dividend Yield | - |
| Shares Outstanding | 62.6M |
| Average Volume (1 week) | 570.15k |
| Average Volume (1 Month) | 896.26k |
| 52 Week Change | 35.58% |
| 52 Week High | 21.28 |
| 52 Week Low | 13.94 |
| Spread (Intraday) | 0.05 (0.26%) |
| Company Name | Innoviva Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
